Tumor-infiltrating lymphocytes predict prognosis of breast cancer patients treated with anti-Her-2 therapy

PURPOSE: Infiltration of tumor associated lymphocytes and count of its different phenotypes are potentially new independent predictor of prognosis in breast cancer. However, research related to it is less reported in breast cancer patients treated with anti-Her-2 therapy. Thus, we evaluated the rela...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Tan-Huan, Zhang, Ying-Chun, Tan, Yu-Ting, An, Xin, Xue, Cong, Deng, Ying-Fei, Yang, Wei, Yuan, Xia, Shi, Yan-Xia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5354903/
https://www.ncbi.nlm.nih.gov/pubmed/28029650
http://dx.doi.org/10.18632/oncotarget.14124

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5354903/
https://www.ncbi.nlm.nih.gov/pubmed/28029650
http://dx.doi.org/10.18632/oncotarget.14124

Ejemplares similares